Search results for "Assaigs"

showing 10 items of 66 documents

Anesthetic efficacy of Oraqix versus Hurricaine and placebo for pain control during non-surgical periodontal treatment

2014

Objectives: To evaluate the efficacy of Oraqix® during scaling and root planing (SRP) in comparison with 20% benzocaine and placebo. Study Design: 15 patients requiring 4 sessions of SRP were enrolled. For each patient, Oraqix®, Hurricaine®, vaseline or no anesthetic product were randomly assigned each to a quadrant. Treatment pain was evaluated on a 100 mm Visual Analog Scale (VAS) and on a Verbal Rating Scale (VRS). The amount of product administered, the need to re-anesthetise, patient and operator satisfaction and the onset of side-effects were also recorded. Results: Oraqix® was significantly better than nothing, with a reduction of VAS score to 13.3 units, but without significant diff…

Local anesthesiaMaleLidocaineBenzocaineRoot PlaningClinical trialsScaling and root planingPain treatmentAnesthesiaPeriodontologyAnesthetics LocalAnestèsia localMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludBenzocaineTreatment OutcomeAnesthesiaUNESCO::CIENCIAS MÉDICASFemaleAnesthesia in dentistryPeriodontal diseasemedicine.drugAdultAnestèsia en odontologiamedicine.medical_specialtyVisual analogue scaleOdontologíaMalalties periodontalsPlaceboPrilocaineVaselineTractament del dolorDouble-Blind MethodmedicineHumansPain ManagementLidocaine Prilocaine Drug CombinationGeneral DentistryAgedbusiness.industryResearchLidocainePrilocaineSurgeryOtorhinolaryngologyAnestheticDental ScalingSurgerybusinessAssaigs clínicsMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Low-level laser therapy in patients with Burning Mouth Syndrome : a double-blind, randomized, controlled clinical trial

2019

Background Evaluate the effect of LLLT in the treatment of burning mouth syndrome (BMS). Material and methods Twenty-one BMS patients were randomly assigned to two groups: 12 in the laser group (LG) and 9 in the control group (CG). Patients in the LG underwent 2-week sessions of LLLT for 4 weeks. The spot tip area of this tool is 0.088cm2, semi-conductor GaAlAs, with a wavelength of 808nm ±5nm (infrared), 200 mW output power, 1.97W/cm2 of power density, 3 J energy per point and application time 15 seconds per point. LLLT was applied punctually, in continuous emissions, on each of the sites where there was a symptom. Symptoms were evaluated with a visual analogue scale (VAS) and patient psyc…

Làsers en odontologiaVisual analogue scalemedicine.medical_treatment030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineClinical trialsmedicineIn patientGeneral DentistryLow level laser therapyUnivariate analysisOral Medicine and Pathologybusiness.industryResearch030206 dentistryBurning mouth syndrome:CIENCIAS MÉDICAS [UNESCO]DysgeusiaClinical trialEstudi de casosLasers in dentistryAnesthesiaUNESCO::CIENCIAS MÉDICASAnalysis of varianceCase studiesmedicine.symptombusinessAssaigs clínics
researchProduct

Mediterranean Diet Maintained Platelet Count within a Healthy Range and Decreased Thrombocytopenia-Related Mortality Risk: A Randomized Controlled Tr…

2021

There is little information on the dietary modulation of thrombosis-related risk factors such as platelet count. We aimed to assess the effects of Mediterranean diet (MedDiet) on platelet count and related outcomes in an older population at high cardiovascular risk. In participants of the PREDIMED (PREvención con DIeta MEDiterránea) study, we assessed whether an intervention with a MedDiet enriched with extra-virgin olive oil or nuts, relative to a low-fat control diet, modulated platelet count (n = 4189), the risk of developing thrombocytosis and thrombocytopenia (n = 3086), and the association between these alterations and all-cause mortality (median follow-up time: 3.0 years). Although p…

Male0301 basic medicineMediterranean dietthrombocytopenia030204 cardiovascular system & hematologyDiet Mediterraneanlaw.inventionClinical trials0302 clinical medicinepreventionRandomized controlled triallawPlateletThrombocytosisNutrition and DieteticsFactors de risc en les malaltiesIncidenceIncidence (epidemiology)Hazard ratioFemaleDietalcsh:Nutrition. Foods and food supplymedicine.medical_specialtyRisk factors in diseaseslcsh:TX341-641ArticleOlder population03 medical and health sciencesMediterranean cookingMediterranean dietInternal medicineCuina mediterràniamedicineHumansAgedProportional Hazards ModelsThrombocytosisPlatelet Countbusiness.industryplatelet countmedicine.diseaseConfidence intervalDiet030104 developmental biologyHeart Disease Risk Factorsrandomized controlled trialbusinessAssaigs clínicsFood ScienceNutrients
researchProduct

Mediterranean diet and quality of life: Baseline cross-sectional analysis of the PREDIMED-PLUS trial

2018

We assessed if a 17-item score capturing adherence to a traditional Mediterranean diet (MedDiet) was associated with better health-related quality of life among older Spanish men and women with overweight or obesity harboring the metabolic syndrome. We analyzed baseline data from 6430 men and women (age 55-70 years) participating in the PREDIMED-Plus study. PREDIMED-Plus is a multi-centre randomized trial testing an energy-restricted MedDiet combined with promotion of physical activity and behavioral therapy for primary cardiovascular prevention compared to a MedDiet alone. Participants answered a 36-item questionnaire about health-related quality of life (HRQoL) and a 17-item questionnaire…

MaleMediterranean dietCross-sectional studyMetabolic disordersSocial Sciencescardiovascular-diseaselaw.invention613 - Higiene en general. Higiene i salut personalEndocrinology0302 clinical medicinepreventionPsychologyPublic and Occupational HealthMental health and psychiatryadherencelcsh:Sciencemediana edadvalidationancianodieta3. Good healthhealth-statusdepressionObesitatDietaEndocrine Disorders03 medical and health sciencesCuina mediterràniaDiabetes MellitusHumansobesidadAgedPhysical activitylcsh:RassociationBiology and Life Sciencesbenefitsmedicine.diseaseObesitymortalityBenefitsAgronomyHealth CareCross-Sectional Studiesphysical-activity questionnairelcsh:QMetabolic syndromeOlder peopleestudios transversalesGerontologycumplimiento del pacienteEmotionshumanoslcsh:Medicine030204 cardiovascular system & hematologyOverweightDiet MediterraneanDieta mediterràniaPersones gransClinical trialsQuality of lifeRandomized controlled triallawPlant ProductsMedicine and Health Sciences030212 general & internal medicine2. Zero hungerMetabolic SyndromeMultidisciplinarysobrepesotratamiento por actividad físicaAgricultureMiddle AgedPhysical-activity questionnaireHealth-statusExercise TherapyQualitat de vidaHypertensionFemalemedicine.symptomResearch ArticleMediterranean cookingMediterranean dietmedicineObesityMortalityNutritionbusiness.industryOverweightMental healthDietSpaincalidad de vidaQuality of LifePatient ComplianceVegetable oilsbusinessCrop ScienceAssaigs clínics
researchProduct

Effect of the local administration of betamethasone on pain, swelling and trismus after impacted lower third molar extraction. A randomized, triple b…

2013

Objectives: The aim of this study is to compare the analgesic and anti-inflammatory effects of the local postoperative administration of a single 12-mg dose of betamethasone after the surgical removal of impacted lower third molars. Study Design: A split-mouth, triple-blind, randomized, placebo-controlled clinical trial of 25 patients requiring the surgical removal of symmetrical lower third molars was performed. In the experimental side, a 12-mg dose of betamethasone was administered submucosally after the surgical procedure, while in the control side a placebo (sterile saline solution) was injected in the same area. To assess postoperative pain, visual analogue scales and the consumption …

MaleMolarAdministration TopicalAnti-Inflammatory AgentsTrismusBetamethasonelaw.inventionPostoperative ComplicationsClinical trialsRandomized controlled triallawEdemaAntiinflammatory agentsEdemaTeeth extractionMedicineProspective StudiesExtracció dentalPain PostoperativeAnalgesicsTooth ImpactedAgents antiinflamatorisDent molar:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludAnesthesiaUNESCO::CIENCIAS MÉDICASBetamethasoneFemaleOral Surgerymedicine.symptommedicine.drugmedicine.medical_specialtyAnalgesicOdontologíaPlaceboYoung AdultAnalgèsicsDouble-Blind MethodHumansGeneral Dentistrybusiness.industryResearchMolarSurgeryClinical trialOtorhinolaryngologyTooth ExtractionMolar ThirdTrismusSurgerybusinessAssaigs clínicsMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Impact of psychosocial factors on cardiovascular morbimortality: a prospective cohort study

2014

[Background] Whilst it is well known that psychosocial determinants may contribute to cardiovascular diseases (CVD), data from specific groups are scarce. The present study aims to determine the contribution of psychosocial determinants in increasing the risk of cardiovascular events (myocardial infarction and stroke), and death from CVD, in a high risk adult population.

MaleTime Factorsmodelos de riesgos proporcionalesEpidemiologyhumanosdepresiónMyocardial Infarction1471-2261Social supportdisparidades en el estado de saludClinical trialsRisk Factorsestudios prospectivosCause of Deathevaluación de riesgosMedicineLongitudinal StudiesProspective StudiesProspective cohort studyStrokemediana edadHealth inequalitiesCause of deathAged 80 and overeducation.field_of_studyancianoDepressionFactors de risc en les malaltiesHazard ratioMiddle AgedPrognosisStrokepronósticoSocioeconomic positionCardiovascular diseasesEstudi de casosEducational StatusFemaleRisk assessmentCardiology and Cardiovascular MedicinePsychosocialResearch Articlemedicine.medical_specialtyRisk factors in diseasesPopulationAcute myocardial infarctionRisk AssessmentEducational levelfactores de tiempocausas de muerteInternal medicinefactores de riesgoHumansanálisis multifactorialaccidente cerebrovascularcardiovascular diseaseseducationEpidemiologiainfarto de miocardioAgedProportional Hazards Modelsbusiness.industryProportional hazards modelMalalties cardiovascularsHealth Status Disparitiesmedicine.diseaseapoyo socialMorbiditatSpainMultivariate AnalysisPhysical therapyHousingCardiovascular deathestudios longitudinalesCase studiesMorbiditybusinessAssaigs clínics
researchProduct

Novel association of the obesity risk-allele near Fas Apoptotic Inhibitory Molecule 2 (FAIM2) gene with heart rate and study of its effects on myocar…

2014

[Background] The Fas apoptotic pathway has been implicated in type 2 diabetes and cardiovascular disease. Although a polymorphism (rs7138803; G > A) near the Fas apoptotic inhibitory molecule 2 (FAIM2) locus has been related to obesity, its association with other cardiovascular risk factors and disease remains uncertain.

MalealelosEndocrinology Diabetes and MetabolismhumanosLOCIMyocardial Infarctionproteínas reguladoras de la apoptosisApoptosisType 2 diabetesVARIANTSDiet Mediterraneanestudios de seguimientoCoronary artery diseaseClinical trialsRisk FactorsMyocardial infarctionLongitudinal Studiesmediana edadOriginal Investigationeducation.field_of_studyancianoDiabetisdietaHàbits alimentarisCAUSE MORTALITYDiabetesSOLUBLE FASMiddle Agedestudios de asociación genéticaMEDITERRANEAN DIETCARDIOVASCULAR-DISEASECORONARY-ARTERY-DISEASEObesitatFemaleCardiology and Cardiovascular Medicinemedicine.medical_specialtyFood habitsPopulationHeart rateproteínas de membranasMediterranean cookingDiabetes mellitusInternal medicineCuina mediterràniamedicineDiabetes MellitusHumansfactores de riesgoJAPANESE POPULATIONGenetic Predisposition to DiseaseObesityGENOME-WIDE ASSOCIATIONeducationobesidadAllelesGenetic Association Studiesinfarto de miocardioAgedPolymorphism Geneticbusiness.industryMembrane Proteinspredisposición genética a la enfermedadmedicine.diseaseObesityFAIM2DietBODY-MASS INDEXInfart de miocardiMyocardial infarctionEndocrinologyBlood pressureDiabetes Mellitus Type 2frecuencia cardíacaestudios longitudinalesbusinessApoptosis Regulatory ProteinsBody mass indexFollow-Up StudiesAssaigs clínics
researchProduct

Dietary Quality Changes According to the Preceding Maximum Weight: A Longitudinal Analysis in the PREDIMED-Plus Randomized Trial

2020

One-year dietary quality change according to the preceding maximum weight in a lifestyle intervention program (PREDIMED-Plus trial, 55–75-year-old overweight or obese adults; n = 5695) was assessed. A validated food frequency questionnaire was used to assess dietary intake. A total of 3 groups were made according to the difference between baseline measured weight and lifetime maximum reported weight: (a) participants entering the study at their maximum weight, (b) moderate weight loss maintainers (WLM), and (c) large WLM. Data were analyzed by General Linear Model. All participants improved average lifestyle. Participants entering the study at their maximum weight were the most susceptible …

Malecumplimiento del pacienteMediterranean diethumanosOverweightDiet Mediterraneanlaw.inventionencuestas sobre dietasClinical trials0302 clinical medicineRandomized controlled trialBehavior TherapyWeight losslawestudios prospectivosWeight managementMedicineLongitudinal StudiesProspective Studies030212 general & internal medicineskin and connective tissue diseasesmediana edadancianoNutrition and Dieteticssobrepesodietaresultado del tratamientoMaximum weightmodelos linealesMiddle AgedWeight Reduction ProgramsTreatment OutcomeBody imageDiet qualityCardiovascular Diseasesestilo de vidaprogramas de reducción de pesoFemaleDietaterapia conductistadietary patternDiet Healthypérdida de pesomedicine.symptommaximum weightlcsh:Nutrition. Foods and food supplybody imageenfermedades cardiovascularesPes corporalDietary patternlcsh:TX341-641030209 endocrinology & metabolismDiet SurveysArticle03 medical and health sciencesMediterranean dietWeight LossHumansObesityLife StyleobesidadAgedGeneral linear modelbusiness.industryPREDIMED-PlusBody weightOverweightPredimedDietLinear ModelsPatient Complianceestudios longitudinalesBody-Weight Trajectorysense organsbusinessAssaigs clínicsFood ScienceDemography
researchProduct

Blood pressure values and depression in hypertensive individuals at high cardiovascular risk

2014

Background: Hypertension and depression are both important risk factors for cardiovascular diseases. Nevertheless, the association of blood pressure on and depression has not been completely established. This study aims to analyze whether depression may influence the control of blood pressure in hypertensive individuals at high cardiovascular risk. Methods: Cross-sectional study, embedded within the PREDIMED clinical trial, of 5954 hypertensive patients with high cardiovascular risk factor profiles. The relationship between blood pressure control and depression was analyzed. A multivariate analysis (logistic and log-linear regression), adjusting for potential confounders (socio-demographic …

Malemodelos logísticoshumanosdepresiónBlood PressureClinical trialsRisk FactorsOdds RatioMedicineDepressió psíquicamediana edadDepression (differential diagnoses)Aged 80 and overancianoantidepresivosDepressionresultado del tratamientomodelos linealesdistribución de la ji al cuadradoMiddle Agedcociente de probabilidades relativasAntidepressive AgentsTreatment OutcomeMental depressionCardiovascular diseasesHypertensionBlood pressureCardiologyHipertensióCardiology and Cardiovascular MedicineResearch Articlepresión sanguíneamedicine.medical_specialtyPressió sanguíniaInternal medicineDiabetes mellitusHumansfactores de riesgoanálisis multifactorialRisk factorAntihypertensive AgentsAgedAngiologyChi-Square DistributionMalalties cardiovascularsbusiness.industryOdds ratiomedicine.diseaseSurgeryCross-Sectional StudiesLogistic ModelsBlood pressureMultivariate AnalysisLinear ModelsantihipertensivoshipertensiónbusinessBody mass indexDyslipidemiaestudios transversalesAssaigs clínicsBMC Cardiovascular Disorders
researchProduct

Drug‐refractory myasthenia gravis: Clinical characteristics, treatments, and outcome

2022

[Objective] To describe the clinical characteristics and outcomes in patients with refractory myasthenia gravis (MG) and to determine the effectiveness and side effects of the drugs used for their treatment.

Maleprogressive multifocal leukoencepdiarrheacholinergic receptorplasma exchangemiddle agedadultimmunologic factornauseaanemiahypertrichosisageddrug withdrawaldiabetes mellitusdisease severityTRIALsafetycorticosteroidhypertensionImmunologyMiastenia gravismethotrexateArticlebulbar paralysispancytopeniaMuscular DiseasescompulsionMyasthenia Gravischolinesterase inhibitorcross-sectional studyHumansImmunologic FactorshumanRITUXIMABarthralgiaNeurologíaMalalties muscularsAgedRetrospective Studiesmyasthenia gravisleukopeniaabdominal painDrug testingmajor clinical studyCross-Sectional StudiesDrug side effectscyclophosphamideobservational studyNeurology (clinical)immunoglobulinFEATURESefficacyclinical outcomeelectrophysiological procedurescomputer assisted tomographyDOUBLE-BLINDTratamiento médicorituximabOutcome Assessment Health CareImmunologiamuscle specific tyrosine kinaseRegistriestacrolimusazathioprineMedicamentoGeneral Neurosciencenephrotoxicitygeneral condition deteriorationhyperplasiatrialMiddle Agedliver toxicitydrug toxicityunclassified drugfemaleEfectes secundaris dels medicamentsSAFETYFemaledouble-blindheadacheblindnessAdultAssaigs clínics de medicamentsmalefeaturesfollow uppneumoniacyclosporinemycophenolate mofetilprotein tyrosine kinaseimmunosuppressive agentallergyalopeciaEFFICACYclinical featureosteopeniaSpainprednisonehyperglycemiaautoantibodyFollow-Up Studies
researchProduct